Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

trecetilide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
To confirm recent in vitro findings, we examined the cardiovascular and electrocardiographic (ECG) effects of the dopamine… Expand
Review
2005
Review
2005
Ibutilide is a ‘pure’ class III antiarrhythmic drug, used intravenously against atrial flutter and fibrillation. At a cellular… Expand
Review
2003
Review
2003
There have been extensive efforts to develop I(Kr) channel blockers as a new antiarrhythmic agent for atrial or ventricular… Expand
Review
2000
Review
2000
  • P. Sager
  • Current opinion in cardiology
  • 2000
  • Corpus ID: 9180245
In the past 2 years, significant advances have been made in class III antiarrhythmic drug therapy. In patients with ventricular… Expand
Review
1999
Review
1999
  • A. Camm, Y. G. Yap
  • Journal of cardiovascular electrophysiology
  • 1999
  • Corpus ID: 41933335
The Next Generation of Antiarrhythmic Drugs. Five drugs currently constitute approximately 70% of the world market for… Expand
1998
1998
Two high-performance liquid chromatography (HPLC) methods were developed for the determination of trecetilide in plasma samples… Expand